stockrowSarepta Therapeutics, Inc.
SRPT Healthcare Biotechnology
Sarepta Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 15.6% from fiscal 2024.
- Revenue
- −4.51%
- EPS
- +46.0%
- Free cash flow
- +231.8%
- Total debt
- −17.2%
Quarter to September 2026, against a year earlier
Follow SRPT
Alert me
Sarepta Therapeutics, Inc. (SRPT) Shares outstanding
Sarepta Therapeutics, Inc.'s shares outstanding at the end of fiscal 2025 was $100.1M, down 7.19% from $107.9M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $105.9M. Over the past ten years it has ranged from $42.3M (fiscal 2015) to $107.9M (fiscal 2024); the current reading is higher than 91% of that period. Sarepta Therapeutics, Inc. ranks 136th of 600 Biotechnology companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $100.1M | (7.19%) |
| FY2024 | $107.9M | 16.75% |
| FY2023 | $92.4M | 5.53% |
| FY2022 | $87.6M | 7.75% |
| FY2021 | $81.3M | 4.24% |
| FY2020 | $78.0M | 5.90% |
| FY2019 | $73.6M | 11.12% |
| FY2018 | $66.3M | 12.64% |
| FY2017 | $58.8M | 20.78% |
| FY2016 | $48.7M | 15.15% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $105.9M | 0.47% |
| Jun 2026 | $105.4M | (13.52%) |
| Mar 2026 | $121.9M | 21.77% |
| Dec 2025 | $100.1M | (0.12%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| VIR Vir Biotechnology, Inc. compare | $169.3M |
| TRVI Trevi Therapeutics, Inc. compare | $156.6M |
| MRVI Maravai LifeSciences Holdings, Inc. compare | $149.1M |
| SRPT Sarepta Therapeutics, Inc. | $105.9M |
| REPL Replimune Group, Inc. compare | $105.2M |
| MESO Mesoblast Limited compare | $77.8M |
| HRMY Harmony Biosciences Holdings, Inc. compare | $59.7M |
| MAZE Maze Therapeutics, Inc. compare | $59.0M |
| TRAX First Tracks Biotherapeutics, Inc. compare | $35.7M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item